PP63 Predictive markers in patients with upper gastrointestinal (GI) cancers treated with erlotinib and bevacizumab in a multicenter phase II trial — Kristoffer Staal Rohrberg (2009) | RDL Network
Antoîne Italiano, Alban Bessede, Emmanuelle Bompas, Sophie Piperno‐Neumann, Christine Chevreau, Nicolas Penel, François Bertucci, Maud Toulmonde, Carine Bellera, Jean‐Philippe Guégan, Catherine Sautès‐Fridman, Antoine Bougoüin, Coralie Cantarel, François Le Loarer, Jean Yves Blay, Wolf H. Fridman
G. Stathopoulos, S. Rigatos, N. Androulakis, John Souglakos, Ch. Kouroussis, Meletios A Dimopoulos, Gerasimos Aravantinos, T. Giannakakis, G. Foutzilas, J. Stathopoulos, Vassilis Georgoulias
Discussion(0)
No comments yet. Be the first to comment.